ASN
SONN

Advisory Services Network’s Sonnet BioTherapeutics SONN Stock Holding History

Advisory Services Network’s Portfolio SONN Stock Details SONN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-636
Closed -$2.91K – 3904
2025
Q3 		$2.91K Buy
+636
New +$2.82K ﹤0.01% 3696
2023
Q3 		– Sell
-406
Closed -$35K – 1538
2023
Q2 		$35K Buy
406
+341
+525% +$24.1K ﹤0.01% 1416
2023
Q1 		$4.12K Buy
65
+12
+23% +$1.94K ﹤0.01% 3211
2022
Q4 		$10.7K Buy
+53
New +$11.6K ﹤0.01% 2828
2022
Q3 		– Sell
-53
Closed -$37K – 1440
2022
Q2 		$37K Buy
53
+32
+152% +$22.9K ﹤0.01% 1346
2022
Q1 		$19K Hold
21
– – ﹤0.01% 1435
2021
Q4 		$21K Buy
21
+8
+62% +$11.5K ﹤0.01% 1390
2021
Q3 		$20K Sell
13
-1
-7% -$2.23K ﹤0.01% 1373
2021
Q2 		$53K Buy
14
+3
+27% +$13.1K ﹤0.01% 1970
2021
Q1 		$61K Buy
11
+1
+10% +$6.32K ﹤0.01% 1260
2020
Q4 		$55K Buy
10
+2
+25% +$12.7K ﹤0.01% 1616
2020
Q3 		$48K Buy
+8
New +$57.7K ﹤0.01% 1615

Other funds holding SONN

FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Advisory Services Network's SONN Position: Q4 2025 in Review

Advisory Services Network sold out of Sonnet BioTherapeutics (SONN) in Q4 2025, closing a stake of 636 shares — an estimated $2.91K sold.

Advisory Services Network first reported a position in SONN in Q3 2020 and held it in 12 quarters. The position peaked at $61K in Q1 2021. 1 fund tracked by Wall St. Rank holds SONN as of Q4 2025.

  • Advisory Services Network reported no remaining Sonnet BioTherapeutics position as of Q4 2025 after selling out during the quarter.
  • Advisory Services Network sold 636 Sonnet BioTherapeutics shares in Q4 2025, an estimated $2.91K.
  • Advisory Services Network first reported a position in Sonnet BioTherapeutics in Q3 2020 and held it in 12 quarters.
  • Advisory Services Network's Sonnet BioTherapeutics position peaked at $61K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Sonnet BioTherapeutics as of Q4 2025.

Based on Advisory Services Network's 13F filing for Q4 2025, filed 17 Feb 2026.